Chicago, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia surgical treatment market was valued at US$ 10.5 billion in 2024 and is expected to reach us$ 16.5 billion by 2033, ...
Based on drug type, the global Benign Prostatic Hyperplasia Surgical Treatment market can be divided into three segments: alpha-blockers (α-blockers), 5-alpha reductase inhibitors (5-ARIs), and other ...
The global Benign Prostatic Hyperplasia Surgical Treatment Market size was valued at USD 2,042.94 million in 2024 and is expected to grow at a CAGR of 5.3% The aging male population's growing need for ...
Astute Analytica stands out as a premier provider of comprehensive Benign Prostatic Hyperplasia Surgical Treatment Market research reports specifically tailored for the healthcare sector. Our ...
Astute Analytica released an extensive market assessment report titled “Global Benign Prostatic Hyperplasia Surgical Treatment Market: Trends, Industry Competition Analysis, Revenue, and Forecast to ...
"The large share of North America can be attributed to the region's highly developed healthcare infrastructure and reimbursement system, the increasing number of advanced treatment procedures like ...
(MENAFN- GlobeNewsWire - Nasdaq) An expanding elderly demographic is fueling growth, while a clear market shift towards minimally invasive procedures challenges the dominance of traditional surgeries, ...
DELRAY BEACH, Fla., Feb. 17, 2025 /PRNewswire/ -- The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, ...
DELRAY BEACH, Fla., Feb. 17, 2025 /PRNewswire/ -- The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback